Oricon Inc. Logo

Oricon Inc.

Provides entertainment industry data, music charts, web media, and marketing services.

4800 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
港区六本木六丁目8番10号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Oricon Inc. is a research and data company focused on transforming facts into intelligence from an objective standpoint. The company operates across three primary business segments. Its Data Providing Business is widely recognized for supplying marketing data and statistics for the entertainment industry, including its influential music charts and comprehensive music databases for e-commerce and broadcasting. The Communication Business manages web media outlets such as 'ORICON NEWS' and 'ORICON Customer Satisfaction' and provides PR and web marketing consulting. The Advertising Business handles the planning and operation of advertising and events. Through these integrated activities, Oricon delivers key insights to both corporate and individual clients, primarily within the entertainment and media sectors.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-27 08:31
Post-Annual General Meeting Information
臨時報告書
Japanese 22.1 KB
2025-06-26 08:41
Governance Information
内部統制報告書-第26期(2024/04/01-2025/03/31)
Japanese 25.0 KB
2025-06-26 08:39
Registration Form
確認書
Japanese 7.9 KB
2025-06-26 08:38
Annual Report
有価証券報告書-第26期(2024/04/01-2025/03/31)
Japanese 881.7 KB
2025-05-14 08:08
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 25.2 KB
2025-04-14 09:52
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 23.3 KB
2025-03-14 09:05
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 23.2 KB
2024-11-07 07:35
Report Publication Announcement
確認書
Japanese 8.0 KB
2024-11-07 07:34
Interim Report
半期報告書-第26期(2024/04/01-2025/03/31)
Japanese 185.6 KB
2024-06-27 08:00
Post-Annual General Meeting Information
臨時報告書
Japanese 22.1 KB
2024-06-26 08:05
Governance Information
内部統制報告書-第25期(2023/04/01-2024/03/31)
Japanese 23.0 KB
2024-06-26 08:04
Registration Form
確認書
Japanese 8.0 KB
2024-06-26 08:02
Annual Report
有価証券報告書-第25期(2023/04/01-2024/03/31)
Japanese 840.0 KB
2024-02-05 07:03
Quarterly Report
四半期報告書-第25期第3四半期(2023/10/01-2023/12/31)
Japanese 152.5 KB
2024-02-05 07:03
Report Publication Announcement
確認書
Japanese 8.0 KB

Automate Your Workflow. Get a real-time feed of all Oricon Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Oricon Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Developing novel cancer immunotherapies, including peptide vaccines and iPS-NKT cell therapies.
Japan 4594
Brilliant Future AB Logo
A data-driven survey platform to measure and improve employee & customer experiences.
Sweden BRILL
b-style holdings,Inc. Logo
Offers flexible staffing for homemakers and specialized recruitment for skilled professionals.
Japan 302A
BTS Group Logo
Helps organizations execute strategy via experiential learning for leadership and sales teams.
Sweden BTS
B.U Technology Logo
Commercializes university research via IP management, licensing, and new venture creation.
South Korea 230980
Advancing high-grade copper and precious metal projects from discovery to production.
Canada N/A
Cantargia Logo
Develops antibody treatments targeting IL1RAP for cancer and autoimmune/inflammatory diseases.
Sweden CANTA
Captor Therapeutics S.A. Logo
Developing TPD therapeutics for oncology and autoimmune diseases with its Optigrade™ platform.
Poland CTX
Offers one-stop BPO, CRM, and staffing for admin, manufacturing, and logistics.
Japan 6070
Carna Biosciences, Inc. Logo
Develops kinase inhibitor drugs for oncology/autoimmune diseases & offers discovery support services.
Japan 4572

Talk to a Data Expert

Have a question? We'll get back to you promptly.